Stada to acquire Takeda OTC portfolio for USD660 mn

5 November 2019 - Deborah Wilkes

Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.